person

Marianne L.

Country
France
Department
Oncologie médicale

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
5
Sites with multiple studies

Has run more than one trial at 5 of 51 partner sites.

Specializations

Advanced Solid Tumors

Focused on the development of targeted therapies for high‑risk malignant neoplasms across multiple organ systems.

  • non‑small cell lung cancer
  • triple‑negative breast cancer
  • metastatic colorectal carcinoma
  • renal cell carcinoma
  • malignant mesothelioma

Research emphasizes molecular profiling and immuno‑oncologic strategies to improve survival outcomes.

Hematologic Malignancies

Investigates innovative approaches for blood‑borne cancers, integrating cellular and molecular modalities.

  • acute myeloid leukemia
  • diffuse large B‑cell lymphoma
  • multiple myeloma
  • chronic lymphocytic leukemia
  • mantle‑cell lymphoma

Efforts aim to overcome resistance mechanisms and optimize transplant‑related outcomes.

Rare and Metabolic Disorders

Addresses therapeutic gaps in low‑prevalence diseases with high unmet medical need.

  • late‑onset Pompe disease
  • AL amyloidosis
  • familial hypercholesterolemia
  • auto‑inflammatory VEXAS syndrome
  • idiopathic pulmonary fibrosis

Clinical programs prioritize biomarker‑driven enrollment and disease‑modifying endpoints.

Cardiovascular and Metabolic Disease

Explores interventions that mitigate vascular risk and metabolic dysfunction.

  • atherosclerotic cardiovascular disease
  • obesity‑related hypertension
  • atrial fibrillation
  • heart failure with reduced ejection fraction
  • type 2 diabetes remission

Studies integrate anti‑inflammatory pathways and lipid‑lowering strategies to reduce major adverse events.

Autoimmune and Inflammatory Conditions

Targets dysregulated immune pathways in systemic and organ‑specific autoimmune diseases.

  • systemic lupus erythematosus
  • vasculitis (ANCA‑associated)
  • moderate‑to‑severe atopic dermatitis
  • idiopathic inflammatory myopathies
  • ulcerative colitis

Therapeutic focus includes cytokine inhibition and precision immunomodulation to achieve durable remission.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.